BeStock  
Stocks › Biotechnology › GPCR

Structure Therapeutics GPCR

US equityMarket cap rank #3061Biotechnology
$16.13 −$0.99 (-5.78%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $16.69 +3.47%
Open$16.73
Prev close$17.12
Day range$16.06 – $17.08
Volume786.2K
Market cap$1.15B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.1x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average -17.1x

Price / book1.2x
CheapRich

Near the bottom of its 5-year range · 11th percentile, 5-year average -316.8x

#1732 of 5330 stocks by PB (1 = cheapest)

P/E over five years

-44x-28x-13x3xJan '23Dec '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$26.08
Price vs. fair value-38.2%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.17 – -316.82 11% (cheaper than usual) #1732 of 5330 (1 = cheapest)
PE -5.13 -2.41 -17.13 99% (pricier than usual) –
PS – 31.19 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on GPCR.

Sign in to join the discussion.

Scroll to Top